Mission BioCapital
Johannes Fruehauf is the General Partner at Mission BioCapital. Previously, Johannes was the Founding Investor and Board Director at Tidal Therapeutics. Johannes holds an MD in Medicine from the Johann Wolfgang Goethe-Universität Frankfurt am Main.